Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Working Capital/Sales

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

GENPHARMASEC Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023
   Working Capital/Sales(x) 1.930.791.51

What is the latest Working Capital/Sales ratio of GENPHARMASEC ?

The latest Working Capital/Sales ratio of GENPHARMASEC is 1.93 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20251.93
Mar20240.79
Mar20231.51

How is Working Capital/Sales of GENPHARMASEC Trending?

Years Working Capital/Sales % Change
Mar2025 1.93
144.30
Mar2024 0.79
-47.68
Mar2023 1.51 -

Other Financial Ratios of GENPHARMASEC


Compare Working Capital/Sales ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹62.6 Cr -0.9% -13.1% -54.2% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹7,187.9 Cr 2.5% -6.4% -7.2% Stock Analytics
KIRI INDUSTRIES ₹2,953.7 Cr 6.7% -9.9% -18.9% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,535.1 Cr -4% -6.6% -33.6% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,071.0 Cr -1.6% -6.6% 22.5% Stock Analytics
BODAL CHEMICALS ₹629.7 Cr 5.1% -3.8% -17.9% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

-0.9%

-13.1%

-54.2%

SENSEX

3.5%

-1.7%

7.8%


You may also like the below Video Courses